Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Change in Receivables (2020 - 2026)

SkinHealth Systems has reported Change in Receivables over the past 6 years, most recently at -$393000.0 for Q4 2025.

  • Quarterly Change in Receivables rose 94.73% to -$393000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.2 million through Dec 2025, up 75.19% year-over-year, with the annual reading at -$5.2 million for FY2025, 75.19% up from the prior year.
  • Change in Receivables was -$393000.0 for Q4 2025 at SkinHealth Systems, up from -$2.5 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $20.3 million in Q2 2022 and troughed at -$10.5 million in Q4 2023.
  • The 5-year median for Change in Receivables is -$2.7 million (2024), against an average of $1.0 million.
  • Year-over-year, Change in Receivables surged 3776.55% in 2021 and then plummeted 198.79% in 2023.
  • A 5-year view of Change in Receivables shows it stood at $13.7 million in 2021, then plummeted by 162.7% to -$8.6 million in 2022, then fell by 22.17% to -$10.5 million in 2023, then increased by 29.08% to -$7.5 million in 2024, then surged by 94.73% to -$393000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Change in Receivables are -$393000.0 (Q4 2025), -$2.5 million (Q3 2025), and $1.7 million (Q2 2025).